A ROGUE pharmacist nicked supplies of weight loss wonder drug Ozempic from his dispensary’s stock room and flogged it on the ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

New year, new you! Getting healthy is a popular resolution and to meet goals, some people may turn to weight-loss drugs for ...

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Hengrui's GLP-1/GIP drug shows 22.8% weight loss at 36 weeks in Phase 2, beating Eli Lilly's retatrutide. Kailera ...

CEO Dave Ricks said Monday that the company's weight-loss pill orforglipron could receive FDA approval as soon as early 2026. Read more here.

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...